The conference Next Generation Nicotine Delivery 2018, taking place in London from 13 to 14 November, will focus on market trends, public health opinion and product innovation in the Next Generation tobacco Products (NGPs), nicotine delivery, and cannabinoid (CBD) categories.

Presented in open learning, interactive sessions, organisers have confirmed key presentations from companies including Philip Morris, Nicopure Labs (USA), Kind Consumer (UK), Considaret (Denmark), VanGo Vapes (Canada) Vape Nation/KIK (UK), among others.
The two-day event will be chaired by Karl Houghton, industry director at GlobalData Consumer, and will address the key themes of understanding customer demands, assessing the CBD phenomenon, and spotlighting on product standards.
Some highlights from the programme include the presentation ‘Uncovering Recent ENDS Scientific Research Data’ by Dr Alexander Nussbaum pf Philip Morris GmbH; ‘Supplying FDA Approved Components into the Nicotine Cessation & CBD Markets’ by Alan Noble of H&T Presspart; ‘Nicotine 2.0: The Next Level Of Nicotine Products’ by David Botton of Element E-Liquid; and ‘Voke: The Development & Launch Of A Medicinally Approved Nicotine Inhaler’ by Wade Tipton of Kind Consumer.
Organisers Arena International told TJI that “the Next Generation Nicotine Delivery conference series has grown to be the go-to conference for the alternative nicotine products category. Since the inception in 2014, attendee numbers have quadrupled, and we expect over 300 industry representatives to join us this year in London. We are proud to be part of the industry and continue to observe Vape and NCP market growth across Europe, and the rest of the world."
See the event website for detailed information on the programme and to Register.